¼¼°èÀÇ ¿ä³×º´ Áø´Ü ½ÃÀå
»óǰÄÚµå : 1781349
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 364 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,180,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,541,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¿ä³×º´ Áø´Ü ¼¼°è ½ÃÀåÀº 2030³â±îÁö 18¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 14¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¿ä³×º´ Áø´Ü ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 5.2%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 18¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®µÇ°í ÀÖ´Â ºÎ¹® Áß ÇϳªÀÎ ¼Ò´Â CAGR 6.3%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 11¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿°¼Ò ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 3.5%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 3¾ï 6,980¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ÇÑÆí Áß±¹Àº CAGR 8.5%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ´Â

¹Ì±¹ÀÇ ¿ä³×º´ Áø´Ü ½ÃÀåÀº 2024³â¿¡ 3¾ï 6,980¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 8.5%·Î 2030³â±îÁö 3¾ï 7,170¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 2.5%¿Í 5.3%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¿ä³×º´ Áø´Ü ¼¼°è ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¿ä³×º´Àº ¼Ò, ¾ç, ¿°¼Ò µî ¹ÝÃßµ¿¹°ÀÌ ÁÖ·Î °É¸®´Â ¸¸¼º Àü¿°¼º À§À庴À¸·Î ÆÄ¶óÃ÷º£¸£Äð¸°ÁõÀ̶ó°íµµ ÇÕ´Ï´Ù. ÀÌ Áúº´Àº Mycobacterium avium subspecies paratuberculosis(MAP)¿¡ ÀÇÇØ ¹ß»ýÇϸç, ½É°¢ÇÑ Ã¼Áß °¨¼Ò, À¯·® °¨¼Ò ¹× ÃÖÁ¾ »ç¸ÁÀ¸·Î À̾îÁ® Ãà»ê¾÷°è¿¡ ½É°¢ÇÑ ¿ì·Á¸¦ ³º°í ÀÖ½À´Ï´Ù. µ¿¹° °Ç°­, ¹ÙÀÌ¿À º¸¾È, ½Äǰ ¾ÈÀü¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ¿ä³×º´ Áø´ÜÁ¦ ½ÃÀåÀº ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. °í±Þ Áø´Ü µµ±¸, °¨½Ã ÇÁ·Î±×·¥ °³¼±, ³ó°¡¿Í ¼öÀÇ»çÀÇ ÀÎ½Ä °³¼±ÀÌ ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¿ä³×º´ Áø´ÜÁ¦ ½ÃÀåÀ» Çü¼ºÇÏ´Â »õ·Î¿î Æ®·»µå´Â?

¿ä³×º´ Áø´ÜÁ¦ ½ÃÀåÀÇ °¡Àå Áß¿äÇÑ Æ®·»µå Áß Çϳª´Â Á¶±â¿¡ Á¤È®ÇÑ Áø´ÜÀ¸·Î ÀüȯÇÏ´Â °ÍÀÔ´Ï´Ù. ±âÁ¸¿¡´Â ºÐº¯ ¹è¾çÀ̳ª Ç÷ûÇÐÀû °Ë»ç µîÀÇ Áø´Ü¹ýÀÌ »ç¿ëµÇ¾î ¿ÔÀ¸³ª, Ãʱ⠴ܰèÀÇ °¨¿°¿¡¼­´Â ³³±â°¡ ±æ°í ¹Î°¨µµ°¡ ³·´Ù´Â ÇѰ谡 ÀÖ¾î º¸´Ù °íµµÀÇ ºÐÀÚ»ý¹°ÇÐÀû-¸é¿ªÇÐÀû ¹æ¹ýÀÌ Ã¤Åõǰí ÀÖ½À´Ï´Ù. ÁßÇÕÈ¿¼Ò ¿¬¼â ¹ÝÀÀ(PCR) ±â¹Ý Áø´Ü¹ýÀº ¹Î°¨µµ, ƯÀ̵µ°¡ ³ô°í, ¹«Áõ»ó °¨¿° »ç·Ê¿¡¼­µµ MAP±ÕÀ» °ËÃâÇÒ ¼ö ÀÖ¾î ¸¹Àº ÁöÁö¸¦ ¹Þ°í ÀÖ½À´Ï´Ù. ½Å¼ÓÇϰí Á¤È®ÇÑ °Ë»ç¿¡ ´ëÇÑ ¿ä±¸´Â º¸´Ù ºü¸¥ °á°ú¿Í Çâ»óµÈ Áúº´ ¸ð´ÏÅ͸µÀ» Á¦°øÇÏ´Â ½Ç½Ã°£ PCR ºÐ¼®ÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¶Ç ´Ù¸¥ Å« Æ®·»µå´Â µ¿¹°¿ë Áø´Ü¿¡ ÀÖ¾î ÇöÀåÁø´Ü(POC) °Ë»ç ¼Ö·ç¼ÇÀÇ ÅëÇÕÀÔ´Ï´Ù. Ãø¸é È帧 ºÐ¼®, ELISA ±â¹Ý ½Å¼Ó °Ë»ç µî ÇöÀå Áø´Ü µµ±¸°¡ ³Î¸® »ç¿ëµÇ¸é¼­ ³ó°¡¿Í ¼öÀǻ簡 Áß¾Ó °Ë»ç ±â°ü¿¡ ÀÇÁ¸ÇÏÁö ¾Ê°íµµ ÇöÀå¿¡¼­ ¿ä³×º´À» °¨ÁöÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ³óÀå ´ÜÀ§ÀÇ Áúº´ °ü¸®¿Í ¹ÙÀÌ¿À º¸¾È¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó, Áúº´ Â÷´ÜÀ» À§ÇÑ Àû½Ã¿¡ °á°ú¸¦ Á¦°øÇÒ ¼ö ÀÖ´Â »ç¿ëÇϱ⠽±°í ºñ¿ë È¿À²ÀûÀÎ ÈÞ´ë¿ë Áø´Ü ŰƮ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, Á¤ºÎ ÁÖµµÀÇ Áúº´ °ü¸® ÇÁ·Î±×·¥°ú °¡Ãà À§»ý ÀÌ´Ï¼ÅÆ¼ºê´Â ½ÃÀå Çü¼º¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¸¹Àº ±¹°¡¿¡¼­ ¿ä³×º´ °¨½Ã ¹× ±ÙÀý ÇÁ·Î±×·¥À» ½ÃÇàÇϰí ÀÖÀ¸¸ç, ¿©±â¿¡´Â °Ë»ç Àǹ«È­, °¡Ã౺ ÀÎÁõ, Áø´Ü °Ë»ç¿¡ ´ëÇÑ ÀçÁ¤Àû Áö¿ø µîÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ³ë·ÂÀ¸·Î Ç¥ÁØÈ­µÈ °í󸮷® Áø´Ü µµ±¸¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 ¿ä³×º´ Áø´Ü¾à ½ÃÀåÀº ´õ¿í È®´ëµÇ°í ÀÖ½À´Ï´Ù. Àü ¼¼°è ±ÔÁ¦ ±â°üÀÌ ¹ÙÀÌ¿À º¸¾È Á¶Ä¡¸¦ °­È­ÇÏ´Â °¡¿îµ¥, Áø´Ü Á¦¾à»çµéÀº °¡Ãà »ý»êÀÚ¿Í ¼öÀÇ»ç Àü¹®°¡µéÀÇ Áõ°¡ÇÏ´Â ¿ä±¸¿¡ ºÎÀÀÇϱâ À§ÇØ Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ» °³¹ßÇϰí ÀÖ½À´Ï´Ù.

±â¼ú ¹ßÀüÀº ¾î¶»°Ô ½ÃÀåÀ» ÁÖµµÇϰí Àִ°¡?

ºÐÀÚÁø´ÜÇÐÀÇ ¹ßÀüÀ¸·Î ¿ä³×º´ÀÇ °ËÃâ È¿À²°ú Á¤È®µµ°¡ Å©°Ô Çâ»óµÇ¾ú½À´Ï´Ù. ÀÌ ºÐ¾ßÀÇ ÁÖ¿ä Çõ½Å Áß Çϳª´Â ¸ÖƼÇ÷º½º PCR ºÐ¼®¹ýÀÇ °³¹ß·Î ¿©·¯ º´¿øÃ¼¸¦ µ¿½Ã¿¡ °ËÃâÇÒ ¼ö ÀÖ°Ô µÇ¾î Áø´Ü¿¡ ¼Ò¿äµÇ´Â ½Ã°£°ú ºñ¿ëÀ» Àý°¨ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®Àº MAP¿Í ±Ù¿¬°ü°è¿¡ ÀÖ´Â ´Ù¸¥ ¸¶ÀÌÄÚ¹ÚÅ׸®¾Æ¸¦ ±¸º°ÇÏ¿© Áø´Ü Á¤È®µµ¸¦ ³ôÀ̰í, ¼öÀǻ簡 ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î Áúº´ °ü¸®¸¦ °áÁ¤ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ¶ÇÇÑ, Â÷¼¼´ë ¿°±â¼­¿­ ºÐ¼®(NGS)Àº MAP ±ÕÁÖÀÇ »ó¼¼ÇÑ À¯ÀüÀÚ ºÐ¼®À» À§ÇØ ¿¬±¸µÇ°í ÀÖÀ¸¸ç, ¿ªÇÐ ¿¬±¸¸¦ °³¼±Çϰí Áúº´ ÀüÆÄÀÇ µ¿¿ªÇÐÀ» ÀÌÇØÇϱâ À§ÇØ ¿¬±¸µÇ°í ÀÖ½À´Ï´Ù.

Áø´Ü ¿öÅ©Ç÷οìÀÇ ÀÚµ¿È­µµ ±â¼úÀû µ¹ÆÄ±¸ Áß ÇϳªÀÔ´Ï´Ù. ÀÚµ¿ ELISA ½Ã½ºÅÛ, PCR Ç÷§Æû, ·Îº¿¿¡ ÀÇÇÑ ½Ã·á 󸮴 ÀÎÀ§ÀûÀÎ ½Ç¼ö¸¦ ÁÙÀ̰í 󸮷®À» Çâ»ó½Ã۸ç, ¿©·¯ ½Ã·á¿¡¼­ ÀϰüµÈ °á°ú¸¦ º¸ÀåÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº È¿À²¼º°ú ÀçÇö¼ºÀÌ Áúº´ ÅëÁ¦¿¡ ÇʼöÀûÀÎ ´ë±Ô¸ð °¡Ãà °Ë»ç ÇÁ·Î±×·¥¿¡ ƯÈ÷ À¯¿ëÇÏ°Ô È°¿ëµÉ ¼ö ÀÖ½À´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý Áø´Ü Ç÷§Æû°ú AI ±â¹Ý µ¥ÀÌÅÍ ºÐ¼® µµ±¸µµ µ¿¹° °Ë»ç ½Ã¼³¿¡ ÅëÇյǾî Áúº´ À¯ÇàÀÇ ½Ç½Ã°£ ÃßÀû°ú ¿¹Ãø ¸ðµ¨¸µÀ» ÅëÇØ ´õ ³ªÀº °¡Ã౺ °Ç°­ °ü¸®¸¦ °¡´ÉÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ¿ä³×º´ Áø´Ü¿¡ ÀÖ¾î ¹ÙÀÌ¿À¼¾¼­¿Í ³ª³ë±â¼úÀÇ È°¿ëÀº Å« ÀáÀç·ÂÀ» °¡Áø ½ÅÈï ºÐ¾ßÀÔ´Ï´Ù. ¿¬±¸°³¹ßÀº ¿ìÀ¯, ºÐº¯, Ç÷¾× µî »ý¹°ÇÐÀû ½Ã·á¿¡¼­ MAP ƯÀÌÀû ¹ÙÀÌ¿À¸¶Ä¿¸¦ °ËÃâÇÏ´Â ¹ÙÀÌ¿À¼¾¼­ ±â¹Ý Áø´ÜÀåÄ¡¸¦ °³¹ßÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ±âÁ¸ Áø´Ü¹ýÀ» ´ëüÇÒ ¼ö ÀÖ´Â º¸´Ù ºü¸£°í, ºñ¿ë È¿À²ÀûÀ̸ç, °í°¨µµ Áø´Ü¹ýÀ» Á¦°øÇÏ´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù. Ãà»ê¾÷°è¿¡¼­´Â Á¤¹Ð³ó¾÷°ú µðÁöÅÐ °Ç°­ ¸ð´ÏÅ͸µÀÇ µµÀÔÀÌ ÁøÇàµÇ°í ÀÖÀ¸¸ç, ¹ÙÀÌ¿À¼¾¼­¿Í AI¸¦ Ȱ¿ëÇÑ Áø´Ü ¼Ö·ç¼ÇÀº ¿ä³×º´ÀÇ °ËÃâ ¹× °ü¸® ¹æ½Ä¿¡ Çõ¸íÀ» °¡Á®¿Ã °ÍÀ¸·Î ±â´ëµÇ°í ÀÖ½À´Ï´Ù.

¿ä³×º´ Áø´Ü ½ÃÀåÀÇ ¼ºÀåÀ» À̲ô´Â ¿äÀÎÀº ¹«¾ùÀϱî?

¿ä³×º´ Áø´Ü ½ÃÀåÀÇ ¼ºÀåÀº °¡Ãà Áúº´¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ¼öÀÇÇÐÀû Áø´Ü ±â¼ú ¹ßÀü, ¿ä³×º´ÀÌ ³«³ó ¹× À°·ù »ý»ê¿¡ ¹ÌÄ¡´Â °æÁ¦Àû ¿µÇâ Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. Áúº´ ¾ø´Â °¡Ãà°ú °íǰÁú À¯Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ³«³ó°¡¿Í »ý»êÀÚµéÀº Á¤±âÀûÀÎ Áúº´ °ËÁø ¹× ¿¹¹æ À§»ý ÇÁ·Î±×·¥¿¡ ÅõÀÚÇϰí ÀÖÀ¸¸ç, ÀÌ¿¡ µû¶ó ½Å·ÚÇÒ ¼ö ÀÖ´Â Áø´Ü °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

Ãà»ê¾÷ È®´ë¿Í µ¿¹° °Ç°­ °ü·Ã ±¹Á¦ ¹«¿ª ±ÔÁ¦µµ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù. ¸¹Àº ±¹°¡¿¡¼­ ¾ö°ÝÇÑ ¼öÃâÀÔ Á¤Ã¥À» ½ÃÇàÇϰí ÀÖÀ¸¸ç, °¡ÃàÀ» °Å·¡Çϰųª ¼öÃâÇϱâ Àü¿¡ ¿ä³×º´À» Æ÷ÇÔÇÑ Àü¿°º´ °Ë»ç¸¦ Àǹ«È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ±¹Á¦ÀûÀ¸·Î ÀÎÁ¤¹Þ´Â Ç¥ÁØÈ­µÈ Áø´Ü °Ë»ç¿¡ ´ëÇÑ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖÀ¸¸ç, Áø´Ü Á¦¾à»çµéÀº ¼¼°è ±ÔÁ¦ ±âÁØ¿¡ ºÎÇÕÇÏ´Â °­·ÂÇÑ ¼Ö·ç¼ÇÀ» °³¹ßÇØ¾ß ÇÏ´Â °úÁ¦¸¦ ¾È°í ÀÖ½À´Ï´Ù.

¶Ç ´Ù¸¥ Áß¿äÇÑ ¿øµ¿·ÂÀº ³«³ó ¹× Ãà»ê »ý»êÀÚµéÀÇ °¡Ã౺ °Ç°­°ü¸® ÇÁ·Î±×·¥ µµÀÔÀÌ È®´ëµÇ°í ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. Áúº´ ¹ß»ýÀº »ý»ê¼º ÀúÇÏ, °¨¿°µÈ µ¿¹°ÀÇ µµÅÂ, ¼öÀÇ»ç ºñ¿ë Áõ°¡·Î ÀÎÇØ Å« °æÁ¦Àû ¼Õ½ÇÀ» ÃÊ·¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±× °á°ú, ¿¹¹æ °Ë»ç¿Í Áúº´ÀÇ Á¶±â ¹ß°ßÀÌ °¡Ã౺ °ü¸® Àü·«ÀÇ ÇʼöÀûÀÎ ¿ä¼Ò°¡ µÇ¾ú½À´Ï´Ù. ºñ¿ë È¿À²ÀûÀ̰í 󸮷®ÀÌ ³ôÀº Áø´Ü ±â¼úÀ» »ç¿ëÇÒ ¼ö ÀÖ°Ô µÊ¿¡ µû¶ó ³«³ó°¡µéÀº ÀÏ»óÀûÀÎ °Ç°­ Æò°¡¿¡ ¿ä³×º´ °ËÁøÀ» ½±°Ô ÅëÇÕÇÒ ¼ö ÀÖ°Ô µÇ¾î ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Ãà»ê¾÷ÀÌ °è¼Ó ÁøÈ­ÇÏ´Â °¡¿îµ¥, Á¤È®ÇÏ°í ½Å¼ÓÇÏ¸ç »ç¿ëÇϱ⠽¬¿î Áø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä´Â °è¼Ó Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ºÐÀÚÁø´Ü, ÀÚµ¿È­, µðÁöÅÐ Çコ ±â¼úÀÇ ¹ßÀüÀ¸·Î ÇâÈÄ ¸î ³â µ¿¾È ¿ä³×º´ÀÇ °ËÃâÀÌ ´õ¿í Çõ½ÅµÇ°í, ´õ ³ªÀº Áúº´ °ü¸®, °¡ÃàÀÇ »ý»ê¼º Çâ»ó, ½Äǰ ¾ÈÀü °­È­°¡ º¸ÀåµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÎ¹®

µ¿¹° À¯Çü(¼Ò, ¿°¼Ò, ¾ç), °Ë»ç À¯Çü(ELISA, PCR, AGID), ÃÖÁ¾»ç¿ëÀÚ(µ¿¹° º´¿ø ¹× Ŭ¸®´Ð, ±âŸ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM ¹× ¾÷°è °íÀ¯ÀÇ SLMÀ» Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹üÀ» µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Johne's Disease Diagnostics Market to Reach US$1.8 Billion by 2030

The global market for Johne's Disease Diagnostics estimated at US$1.4 Billion in the year 2024, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Cattle, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Goat segment is estimated at 3.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$369.8 Million While China is Forecast to Grow at 8.5% CAGR

The Johne's Disease Diagnostics market in the U.S. is estimated at US$369.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$371.7 Million by the year 2030 trailing a CAGR of 8.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Johne’s Disease Diagnostics Market - Key Trends & Drivers Summarized

Johne’s disease, also known as paratuberculosis, is a chronic, infectious gastrointestinal disease that primarily affects ruminants such as cattle, sheep, and goats. Caused by Mycobacterium avium subspecies paratuberculosis (MAP), the disease leads to severe weight loss, reduced milk production, and eventual mortality, making it a significant concern for the livestock industry. With the increasing emphasis on animal health, biosecurity, and food safety, the Johne’s disease diagnostics market is experiencing rapid growth. Advanced diagnostic tools, improved surveillance programs, and rising awareness among farmers and veterinarians are driving market expansion.

What Are the Emerging Trends Shaping the Johne’s Disease Diagnostics Market?

One of the most critical trends in the Johne’s disease diagnostics market is the shift toward early and accurate detection. Traditionally, diagnostic methods such as fecal culture and serology were used, but their limitations, including long turnaround times and low sensitivity in early-stage infections, have led to the adoption of more advanced molecular and immunological techniques. Polymerase Chain Reaction (PCR)-based diagnostics are gaining traction due to their higher sensitivity, specificity, and ability to detect MAP bacteria even in subclinical cases. The demand for rapid and accurate testing is driving the adoption of real-time PCR assays, which offer quicker results and improved disease monitoring.

Another significant trend is the integration of point-of-care (POC) testing solutions in veterinary diagnostics. On-site diagnostic tools such as lateral flow assays and ELISA-based rapid tests are becoming more widely available, allowing farmers and veterinarians to detect Johne’s disease in the field without relying on centralized laboratories. The growing emphasis on farm-level disease management and biosecurity is fueling the demand for easy-to-use, cost-effective, and portable diagnostic kits that can provide timely results for disease containment.

Additionally, government-led disease control programs and livestock health initiatives are playing a crucial role in shaping the market. Many countries have implemented Johne’s disease surveillance and eradication programs, which include mandatory testing, herd certification, and financial support for diagnostic testing. These initiatives are driving the demand for standardized and high-throughput diagnostic tools, further strengthening the market for Johne’s disease diagnostics. As global regulatory bodies tighten biosecurity measures, diagnostic companies are developing innovative solutions to meet the growing needs of livestock producers and veterinary professionals.

How Are Technological Advancements Driving the Market?

The advancement of molecular diagnostics has significantly improved the efficiency and accuracy of Johne’s disease detection. One of the key innovations in this sector is the development of multiplex PCR assays, which allow simultaneous detection of multiple pathogens, reducing diagnostic time and costs. These assays enhance diagnostic accuracy by differentiating MAP from other closely related mycobacteria, helping veterinarians make informed disease management decisions. Additionally, next-generation sequencing (NGS) is being explored for in-depth genetic analysis of MAP strains, improving epidemiological studies and understanding disease transmission dynamics.

Another technological breakthrough is the automation of diagnostic workflows. Automated ELISA systems, PCR platforms, and robotic sample processing are reducing human error, increasing throughput, and ensuring consistent results across multiple samples. These advancements are particularly beneficial for large-scale herd testing programs, where efficiency and reproducibility are critical for disease control efforts. Cloud-based diagnostic platforms and AI-driven data analysis tools are also being integrated into veterinary laboratories, allowing for real-time tracking of disease prevalence and predictive modeling for better herd health management.

Furthermore, the use of biosensors and nanotechnology in Johne’s disease diagnostics is an emerging field with significant potential. Researchers are developing biosensor-based diagnostic devices that detect MAP-specific biomarkers in biological samples such as milk, feces, and blood. These technologies aim to offer faster, more cost-effective, and highly sensitive alternatives to conventional diagnostic methods. As the livestock industry increasingly adopts precision farming and digital health monitoring, biosensors and AI-driven diagnostic solutions are expected to revolutionize the way Johne’s disease is detected and managed.

What Is Driving the Growth of the Johne’s Disease Diagnostics Market?

The growth in the Johne’s disease diagnostics market is driven by several factors, including increasing awareness of livestock diseases, technological advancements in veterinary diagnostics, and the growing economic impact of Johne’s disease on dairy and meat production. The rising demand for disease-free livestock and high-quality dairy products has prompted farmers and producers to invest in regular disease screening and preventive health programs, boosting the demand for reliable diagnostic tests.

The expansion of the livestock industry and international trade regulations regarding animal health are also key drivers. Many countries have implemented strict import-export policies that require livestock to be tested for infectious diseases, including Johne’s disease, before they can be traded or exported. This has increased the need for standardized and internationally recognized diagnostic tests, encouraging diagnostic companies to develop robust solutions that comply with global regulatory standards.

Another critical driver is the growing adoption of herd health management programs by dairy farms and livestock producers. Disease outbreaks can lead to significant economic losses due to reduced productivity, culling of infected animals, and increased veterinary costs. As a result, preventive testing and early disease detection have become integral parts of herd management strategies. The increasing availability of cost-effective and high-throughput diagnostic technologies is making it easier for farmers to incorporate Johne’s disease screening into routine health assessments, further driving market growth.

As the livestock industry continues to evolve, the demand for accurate, rapid, and accessible diagnostic solutions will remain strong. Advancements in molecular diagnostics, automation, and digital health technologies are expected to further revolutionize Johne’s disease detection, ensuring better disease control, improved herd productivity, and enhanced food safety in the years to come.

SCOPE OF STUDY:

The report analyzes the Johne's Disease Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Animal Type (Cattle, Goat, Sheep); Test Type (ELISA, PCR, AGID); End-Use (Veterinary Hospitals & Clinics, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â